Ann: Half Yearly Results Timing & Investor Update Call, page-16

Just to note, regarding the 31 December cash balance of $7.4m
- there will also be indicated grant receipts of $2m this year ($1.4m Queensland + $0.6m Arena) and an R&D refund towards the end of this year of around $2.5m.

- so likely available cash this financial year of $12m before any sales.

Add in SII which could be $1m this year and the start of "material receipts" from Vidicare and we're looking at $13m+ cash being available

Also there is potential of funding or agreement dollars from Mercedes around the half year and anything else that may come through